Literature DB >> 10446137

Further delineation of the two binding sites (R*(n)) associated with tachykinin neurokinin-1 receptors using [3-Prolinomethionine(11)]SP analogues.

S Sagan1, P Karoyan, G Chassaing, S Lavielle.   

Abstract

Two binding sites are associated with neurokinin-1 substance P receptors in both transfected cells and mammalian tissues. To further delineate the interactions between the crucial C-terminal methionine of substance P and these two binding sites, we have incorporated newly designed constrained methionines, i.e. (2S, 3S)- and (2S,3R)-prolinomethionines. The potencies of these C terminus-modified SP analogues to bind both sites and to activate phosphatidylinositol hydrolysis and cAMP formation have been measured, together with those of their corresponding sulfoxides and sulfones. The molecular nature of these two binding sites and their selective coupling to effector signaling pathways are discussed in the light of current models of receptor activation. The less abundant binding site is coupled to G(q/11) proteins, whereas the most abundant one interacts with G(s) proteins in Chinese hamster ovary cells transfected with human neurokinin-1 receptors. The specific orientation of the C-terminal methionine side chain imposed by these constraints shows that macroscopically chi(1) and chi(2) angles of this crucial C-terminal residue are similar in both binding sites. However, slight but significant variations in the rotation around the Cgamma-S bond yield different either stabilizing or destabilizing interactions in the two binding sites. These results highlight the need of such constrained amino acids to probe subtle interactions in ligand-receptor complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446137     DOI: 10.1074/jbc.274.34.23770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  The origins of diversity and specificity in g protein-coupled receptor signaling.

Authors:  Stuart Maudsley; Bronwen Martin; Louis M Luttrell
Journal:  J Pharmacol Exp Ther       Date:  2005-04-01       Impact factor: 4.030

3.  [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.

Authors:  Cristiana Griffante; Renzo Carletti; Filippo Andreetta; Mauro Corsi
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

4.  The two NK-1 binding sites correspond to distinct, independent, and non-interconvertible receptor conformational states as confirmed by plasmon-waveguide resonance spectroscopy.

Authors:  Isabel D Alves; Diane Delaroche; Bernard Mouillac; Zdzislaw Salamon; Gordon Tollin; Victor J Hruby; Solange Lavielle; Sandrine Sagan
Journal:  Biochemistry       Date:  2006-04-25       Impact factor: 3.162

5.  Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor.

Authors:  Morris F Tansky; Charalabos Pothoulakis; Susan E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

6.  Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation.

Authors:  Yolande Cordeaux; Adriaan P Ijzerman; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.